AVANIR Pharmaceuticals To paticipate in two conferences in March PR Newswire ALISO VIEJO, Calif., March 1, 2013 ALISO VIEJO, Calif., March 1, 2013 /PRNewswire/ --Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that company management will present an overview of the company at the following conferences in March. (Logo: http://photos.prnewswire.com/prnh/20130207/LA55901LOGO) oCowen & Company 33^rd Annual Healthcare Conference oLocation: Boston Marriott Copley Place, Boston, MA oPresentation date: Tuesday March 5, 2013 oPresentation time: 9:20 a.m. E.T. o25^th Annual ROTH Conference oLocation: Ritz-Carlton, Laguna Niguel, CA oPresentation date: Wednesday March 20, 2013 oPresentation time: 11:30 a.m. P.T. A live webcast and 30-day archive of these presentations will be available at http://ir.avanir.com. About Avanir Pharmaceuticals, Inc. Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit www.avanir.com. AVANIR® is a trademark or registered trademark of Avanir Pharmaceuticals, Inc. in the United States and other countries. ^©2013 Avanir Pharmaceuticals, Inc. All Rights Reserved. Avanir Investor & Media Contact Ian Clements, PhD firstname.lastname@example.org +1 (949) 389-6700 SOURCE Avanir Pharmaceuticals, Inc. Website: www.avanir.com
Norwegian Cruise to Buy Prestige Cruises for $3.03 Billion With Debt
AVANIR Pharmaceuticals To paticipate in two conferences in March
Press spacebar to pause and continue. Press esc to stop.